MedPath

Revac B+

Brand Name: Revac B+

Generic Name: Hepatitis B Vaccine (rDNA)

Active
Registration Number

BR-724

Dosage Form

Solution For Injection (IM)

Issuance Date

December 23, 2024

Expiry Date

April 14, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength20 mcg/mL
Packaging1 mL Type I glass vial (Box of 1's). Single adult dose

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Vaccine
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Hepatitis B Vaccine (rDNA)Active
Monograph: hepatitis b vaccine (rdna)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform